Area of research
Epidemiology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Internal medicine, Endocrinology, Adiponectin, Extracellular matrix, Pressure overload, and Mef2.
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF)
Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart
Abstract P2139: The Adiponectin Receptor Agonist ALY688 Prevents Pressure Overload-induced Cardiac Dysfunction And Adverse Cardiac Remodeling
An adiponectin-S1P axis protects against lipid induced insulin resistance and cardiomyocyte cell death via reduction of oxidative stress
Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetes
Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
Cellular, structural and functional cardiac remodelling following pressure overload and unloading
Pressure Overload-Induced Cardiac Dysfunction in Aged Male Adiponectin Knockout Mice Is Associated With Autophagy Deficiency
Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy
Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice
Mechanisms of Cardiac Fibrosis and Heart Failure
Abstract 129: Inhibition of MEF2 By Atenolol Modifies the Transcriptome During Cardiac Hypertrophy to Improve Heart Function
Adiponectin Mediated APPL1-AMPK Signaling Induces Cell Migration, MMP Activation, and Collagen Remodeling in Cardiac Fibroblasts